Mirum Pharmaceuticals
M$0
21
+M$0+0% Tuesday 11:30
Statistik
Harga Tertinggi Hari Ini
629.79
Harga Terendah Hari Ini
629.79
52M Tinggi
629.79
52M Rendah
426.02
Volume
0
Rata-Rata Volume
138
Kap Pasar
14.3B
Rasio P/E
-
Hasil Dividen
-
Dividen
-
Mendatang
Pendapatan
6NovDiharapkan
EPS yang Diharapkan
-0.431434
EPS Aktual
T/A
Orang Juga Mengikuti
Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti MIRM.MX. Ini bukan rekomendasi investasi.
Peserta
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Vertex Pharmaceuticals
VRTX
Kap Pasar127.99B
Alnylam Pharmaceuticals
ALNY
Kap Pasar33.72B
Gilead Sciences
GILD
Kap Pasar98.35B
Abbvie
ABBV
Kap Pasar346.75B
Pfizer
PFE
Kap Pasar164.39B
Novartis
NVS
Kap Pasar244.75B
Merck
MRK
Kap Pasar300.25B
Astrazeneca
AZN
Kap Pasar271.67B
Bristol-Myers Squibb
BMY
Kap Pasar101.27B
Tentang
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
Show more...
CEO
Mr. Christopher Peetz
Karyawan
194
Negara
United States
ISIN
US6047491013